Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Paly
Prs24 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Ff/Vi and Umec/Vi in Patients With Copd: Healthcare Resource Utilization Data and Associated Costs – Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI and UMEC/VI in Patients With COPD: Efficacy and Safety in a Japanese Population
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Prs44 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Umec/Vi in Patients With Copd: Cost-Effectiveness Analysis From a Societal Perspective in Quebec
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs46 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Ff/Vi in Patients With Copd: Cost-Effectiveness Analysis From a Societal Perspective in Quebec
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs21 - Economic Impact of Delaying Initiation With Multiple Inhaler Maintenance Triple Therapy Treatment in Spanish Copd Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Determinants of Elevated Healthcare Utilization in Patients With COPD
Respiratory Research
Pulmonary
Respiratory Medicine
Prs39 - Cost-Effectiveness of a New Single Inhaler Triple Therapy (Sitt) Versus Multiple Inhaler Triple Therapies (Mitt) to Treat Chronic Obstructive Pulmonary Disease (Copd) in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs57 - Economic Evaluation of Single Inhaler Triple Therapy for Patients With Chronic Obstructive Pulmonary Disease (Copd) Using the Galaxy Model
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P272 Improvements in Exacerbation Rates With Single Inhaler Triple Therapy Versus Dual Ics/Laba Therapy in Patients With Advanced Chronic Obstructive Pulmonary Disease (Copd): Subgroup Analyses of the Phase Iii Fulfil Study
P272 Improvements in Exacerbation Rates With Single Inhaler Triple Therapy Versus Dual Ics/Laba Therapy in Patients With Advanced Chronic Obstructive Pulmonary Disease (Copd): Subgroup Analyses of the Phase Iii Fulfil Study
